Is a complete CELU research report available?

No complete published report is available for Celularity Inc. (CELU) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Celularity Inc. (CELU)

NASDAQ: CELU · USD

$0.68

+0.01 (+1.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CELU analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	19.7M
Revenue (ttm)	26.6M
Net income (ttm)	-91.8M
EPS (ttm)	-$3.59
Shares out	28.9M
Volume	18,080
Beta	0.54

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 26.6M
Net income (ttm): -91.8M
EPS (ttm): -$3.59
Market cap: 19.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CELU indicators

Market & fundamental data

Available fields

193

Groups with data

Currency

USD

Showing 193 of 193 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001752828
Company name	Celularity Inc.
Country	United States
Country code	US
Cusip	151190204
Employees	115
Employees Change	-8%
Employees Change Percent	-6.5
Enterprise value	$88.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US1511902041
Last refreshed	2026-07-31
Market cap	$19.7M
Market cap category	Nano-Cap
Price	$0.68
Price currency	USD
Rev Per Employee	230,869.57x
Sector	Healthcare
Sector PE	45.64
Sector PE Fwd	24.21
Sic	2834
Symbol	CELU
Website	https://www.celularity.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-466.39%
EV/Sales	3.32x
FCF yield	-67.34%
P/S ratio	0.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-230.92%
EBITDA Margin	-203.44%
Gross margin	24.39%
Gross Profit	$6.5M
Gross Profit Growth	-83.49%
Gross Profit Growth5 Y	-7.07%
Net Income	$-91.8M
Net Income Growth Years	0%
Pretax Margin	-345.44%
Profit Per Employee	$-798,261
ROA	-30.93
Roa5y	-21.8
ROCE	-228.2
ROIC	-156.7
Roic5y	-119.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-78.71%
Cagr3y	-44.26%
Cagr5y	-62.2%
EPS Growth Years	0
Revenue Growth	-51.03x
Revenue Growth Q	-77.37x
Revenue Growth Years	0x
Revenue Growth3 Y	13.88x
Revenue Growth5 Y	13.21x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.22
Assets	$107.3M
Cash	$6.2M
Current Assets	$12.3M
Current Liabilities	$80.5M
Debt	$74.7M
Equity	$-37.8M
Interest Coverage	-9.08
Liabilities	$145.1M
Long Term Assets	$95M
Long Term Liabilities	$64.6M
Net Cash	$-68.5M
Net Cash By Market Cap	$-348
Tangible Book Value	$-53.2M
Tangible Book Value Per Share	$-1.84
WACC	7.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.15
Inventory Turnover	6.71
Net Working Capital	$-58.2M
Quick ratio	0.13
Working Capital	$-68.1M
Working Capital Turnover	$-0.52

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.94%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-78.68%
200-day SMA	1.25
3Y total return	-82.69%
50-day SMA	0.78
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.23%
All Time High	134
All Time High Change	-99.49%
All Time High Date	2021-07-20
All Time Low	0.56
All Time Low Change	21.41%
All Time Low Date	2026-06-30
ATR	0.07
Beta	0.54
Beta1y	1.15
Beta2y	3.18
Ch YTD	-38.74
High	0.72
High52	4.31
High52 Date	2025-08-18
High52ch	-84.22%
Low	0.68
Low52	0.56
Low52 Date	2026-06-30
Low52ch	21.41%
Ma50ch	-13.2%
Premarket Change Percent	0.01
Premarket Price	$0.67
Premarket Volume	310
Price vs 200-day SMA	-45.69%
RSI	40.18
RSI Monthly	33.16
RSI Weekly	34.03
Sharpe ratio	-1.24x
Sortino ratio	-1.64
Total Return	-16.94%
Tr YTD	-38.74
Tr1m	12.16%
Tr1w	-10.53%
Tr3m	-29.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-59.4M
Operating margin	-223.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	18,869,133%
Float Percent	65.19%
Net Borrowing	10,791,000
Shares Insiders	12.24%
Shares Institutions	13.14%
Shares Out	28,945,961
Shares Qo Q	8%
Shares Yo Y	16.94%
Short Float	2.22%
Short Ratio	2.58
Short Shares	1.45

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-23.9M
Adjusted OCF	-23,896,000
Average Volume	98,600.15x
Bv Per Share	-1.32
Ch1m	12.16
Ch1w	-10.53
Ch1y	-78.68
Ch3m	-29.17
Ch3y	-82.69
Ch5y	-99.23
Ch6m	-46.33
Change	1.48%
Change From Open	0
Close	0.67
Days Gap	1.48
Depreciation Amortization	5,384,000
Dollar Volume	12,294.4
Earnings Date	2026-08-28
Earnings Time	amc
EBIT	$-61.3M
EBITDA	$-54M
EPS	$-3.59
F Score	2
FCF	$-13.3M
FCF EV Yield	-15.02x
FCF Per Share	$-0.46
Financing CF	18,649,000
Fiscal Year End	December
Founded	2,016
Goodwill	7,347,000
Income Tax	$3,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2025-12-31
Last Split Date	2024-02-29
Last Split Type	Reverse
Last10k Filing Date	2026-04-30
Ma150	1.06
Ma150ch	-36.09%
Ma20	0.75
Ma20ch	-8.99%
Net CF	5,395,000
Next Earnings Date	2026-08-28
Open	0.68
Optionable	Yes
Position In Range	0
Post Close	0.68
Postmarket Change Percent	1.47
Postmarket Price	$0.69
Ppne	66,517,000
Pre Close	0.67
Price Date	2026-07-30
Relative Volume	0.18x
Revenue	26,550,000x
SBC By Revenue	40.08x
Share Based Comp	10,642,000
Tax By Revenue	0.01x
Tr6m	-46.33%
Us State	New Jersey
Volume	18,080
Z Score	-15.06

Celularity Inc. (CELU)

Coverage state: Market snapshot only — no published research

Generate the first CELU analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CELU

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CELU indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CELU

Frequently asked questions